Submitted by Anonymous (not verified) on 20 October 2026 - 15:15
Human medicines European public assessment report (EPAR): Kanjinti, trastuzumab, Date of authorisation: 16/05/2018, Revision: 13, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Kanjinti, trastuzumab, Date of authorisation: 16/05/2018, Revision: 13, Status: Authorised